Achilles Therapeutics plc (ACHL)
Mar 20, 2025 - ACHL was delisted pending liquidation
1.480
0.00 (0.00%)
Inactive · Last trade price on Mar 21, 2025

Achilles Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Achilles Therapeutics stock had an average target of $4.00, with a low estimate of $2.00 and a high estimate of $6.00.

Price Target: $4.00 (+170.27%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$2.00$4.00n/a$6.00
Change+35.14%+170.27%n/a+305.41%

Analyst Ratings

The average analyst rating for Achilles Therapeutics stock from 2 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.18
from -1.74
EPS Next Year
-0.12
from -0.18
Fiscal YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Period EndingDec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
EPS
-21.79-31.14-2.13-1.82-1.74-0.18-0.12
No. Analysts
-----33

Revenue Forecast

Revenue2024202520262027
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth2024202520262027
High--
Avg--
Low--

EPS Forecast

EPS2024202520262027
High-0.19-0.13
Avg-0.18-0.12
Low-0.18-0.12

EPS Growth

EPS Growth2024202520262027
High--
Avg--
Low--